{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:01:03Z","timestamp":1785456063660,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["5T32AA029975"],"award-info":[{"award-number":["5T32AA029975"]}]},{"name":"NIH","award":["DK115377, 2R56DK115377-05A1, 5R01AA030180, R01DK139587, NIH-NCI P01CA275740"],"award-info":[{"award-number":["DK115377, 2R56DK115377-05A1, 5R01AA030180, R01DK139587, NIH-NCI P01CA275740"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5I01BX005730,1 IS1 BX004777-01 and 1IS1BX005517-01, IK6BX004477"],"award-info":[{"award-number":["5I01BX005730,1 IS1 BX004777-01 and 1IS1BX005517-01, IK6BX004477"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite recent advances, Primary Sclerosing Cholangitis (PSC)-a chronic obstructive biliary disease-still lacks effective therapies to prevent disease progression or the need for liver transplantation. Moreover, up to 30% of transplant recipients experience recurrence. Long non-coding RNA H19 (H19) has been implicated in promoting PSC progression, yet the cellular and molecular mechanisms underlying its pathogenic role remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Liver tissues from age- and sex-matched wild type (WT), H19 knockout (H19KO), Mdr2 knockout (Mdr2KO), and double-knockout (DKO; Mdr2KO\/H19KO) mice were analyzed using single-nucleus RNA sequencing (snRNAseq) and GeoMx spatial transcriptomics to define the cell type and spatially specific effects of H19 deletion in cholestatic liver injury. Machine learning models were built to develop cell-type-specific gene prediction signatures and cross-validated using the human dataset GSE243981. A disease-associated cholangiocyte subcluster that increased in Mdr2KO but was markedly reduced in DKO mice was identified. SPP1 signaling was significantly dysregulated in cholestatic liver injury and mitigated following H19 deletion. Translationally conserved healthy (Clu, Spp1) and diseased (Csmd1, Slco3a1, Cftr) cholangiocyte markers were identified. When validated in a human patient dataset (GSE243981), our machine-learning prediction models achieved AUC values\u2009&gt;\u20090.869. Finally, spatial analyses demonstrated that the mitigation of disease-associated gene expression following H19 deletion was specifically restricted to hepatocytes within the bile duct region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>H19 deletion mitigates cholestatic injury by suppressing pathogenic cholangiocyte states, normalizing Spp1-mediated signaling, and shifting transcriptional programs specifically within the periductal niche. Furthermore, our machine-learning signatures demonstrate robust cross-species translation and may benefit future post-transplant analytics and disease recurrence predictions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-026-01590-3","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:30:00Z","timestamp":1780068600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the role of H19 in cholestatic liver injury using snRNA-seq, spatial transcriptomics, and machine learning-based disease prediction"],"prefix":"10.1186","volume":"16","author":[{"given":"Grayson W.","family":"Way","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-ling","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareh","family":"Bayatpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.510300101","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology. 1999;30:325\u201332.","journal-title":"Hepatology"},{"key":"1590_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382:1587\u201399.","journal-title":"Lancet"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67:1298\u2013323.","journal-title":"J Hepatol"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521\u201336.","journal-title":"Gastroenterology"},{"key":"1590_CR5","first-page":"427","volume":"14","author":"JH Tabibian","year":"2018","unstructured":"Tabibian JH, Ali AH, Lindor KD. Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance. Gastroenterol Hepatol (N Y). 2018;14:427\u201332.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang JYL, Ferrell JM. Bile Acids as Metabolic Regulators and Nutrient Sensors. Annu Rev Nutr. 2019;39:175\u2013200.","journal-title":"Annu Rev Nutr"},{"key":"1590_CR7","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318:G554\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.livres.2017.03.002","volume":"1","author":"PB Hylemon","year":"2017","unstructured":"Hylemon PB, Takabe K, Dozmorov M, Nagahashi M, Zhou H. Bile acids as global regulators of hepatic nutrient metabolism. Liver Res. 2017;1:10\u20136.","journal-title":"Liver Res"},{"issue":"10","key":"1590_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/CM9.0000000000002156","volume":"135","author":"KG Jackson","year":"2022","unstructured":"Jackson KG, Way GW, Zhou H. Bile acids and sphingolipids in non-alcoholic fatty liver disease. Chin Med J. 2022;135(10):1163\u201371.","journal-title":"Chin Med J"},{"issue":"8","key":"1590_CR10","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/cells11081374","volume":"11","author":"GW Way","year":"2022","unstructured":"Way GW, Jackson KG, Muscu SR, Zhou H. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids. Cells. 2022;11(8):1374.","journal-title":"Cells"},{"key":"1590_CR11","first-page":"293","volume":"14","author":"JH Tabibian","year":"2018","unstructured":"Tabibian JH, Ali AH, Lindor KD. Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment. Gastroenterol Hepatol (N Y). 2018;14:293\u2013304.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/hep.31765","volume":"74","author":"Y Wang","year":"2021","unstructured":"Wang Y, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Key Player in Liver Diseases. Hepatology. 2021;74:1652\u20139.","journal-title":"Hepatology"},{"issue":"2","key":"1590_CR13","first-page":"19","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zeng J, Chen W, Fan J, Hylemon PB, Zhou H. Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer. Noncoding RNA. 2023;9(2):19.","journal-title":"Noncoding RNA"},{"key":"1590_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.29838","volume":"68","author":"X Li","year":"2018","unstructured":"Li X, Liu R, Huang Z, Gurley EC, Wang X, Wang J, He H, et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology. 2018;68:599\u2013615.","journal-title":"Hepatology"},{"issue":"1","key":"1590_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cells9010190","volume":"9","author":"X Li","year":"2020","unstructured":"Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X, Yang H, et al. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions. Cells. 2020;9(1):190.","journal-title":"Cells"},{"key":"1590_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.29145","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Liu R, Yang J, Sun L, Zhang L, Jiang Z, Puri P, et al. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice. Hepatology. 2017;66:869\u201384.","journal-title":"Hepatology"},{"key":"1590_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30662","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, Gurley EC, et al. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis. Hepatology. 2019;70:1317\u201335.","journal-title":"Hepatology"},{"issue":"1","key":"1590_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13578-022-00910-7","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tai YL, Way G, Zeng J, Zhao D, Su L, Jiang X, et al. RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression. Cell Biosci. 2022;12(1):172.","journal-title":"Cell Biosci"},{"key":"1590_CR19","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/hep.30698","volume":"70","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Liu R, Li X, Gurley EC, Hylemon PB, Lu Y, Zhou H, et al. Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Hepatology. 2019;70:1658\u201373.","journal-title":"Hepatology"},{"key":"1590_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.2018090912","volume":"30","author":"H Wu","year":"2019","unstructured":"Wu H, Kirita Y, Donnelly EL, Humphreys BD. Advantages of Single-Nucleus over Single-Cell RNA Sequencing of Adult Kidney: Rare Cell Types and Novel Cell States Revealed in Fibrosis. J Am Soc Nephrol. 2019;30:23\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"1590_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"1590_CR22","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. In: R Foundation for Statistical Computing; 2024."},{"key":"1590_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"1590_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"1590_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, Zhang F, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496\u2013502.","journal-title":"Nature"},{"key":"1590_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"1590_CR27","doi-asserted-by":"crossref","unstructured":"Tay JK, Narasimhan B, Hastie T. Elastic Net Regularization Paths for All Generalized Linear Models. J Stat Softw 2023;106.","DOI":"10.18637\/jss.v106.i01"},{"key":"1590_CR28","doi-asserted-by":"crossref","unstructured":"Hua Y, Weng L, Zhao F, Rambow F. SeuratExtend: streamlining single-cell RNA-seq analysis through an integrated and intuitive framework. Gigascience 2025;14.","DOI":"10.1093\/gigascience\/giaf076"},{"key":"1590_CR29","doi-asserted-by":"crossref","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson H. gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res 2020;9.","DOI":"10.12688\/f1000research.24956.1"},{"key":"1590_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"1590_CR31","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1093\/nar\/gkad1026","volume":"52","author":"N Liu","year":"2024","unstructured":"Liu N, Bhuva DD, Mohamed A, Bokelund M, Kulasinghe A, Tan CW, Davis MJ. standR: spatial transcriptomic analysis for GeoMx DSP data. Nucleic Acids Res. 2024;52:e2.","journal-title":"Nucleic Acids Res"},{"key":"1590_CR32","doi-asserted-by":"crossref","unstructured":"McInnes L, Healy J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction. ArXiv. 2018. abs\/1802.03426.","DOI":"10.21105\/joss.00861"},{"key":"1590_CR33","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1590_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1590_CR35","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41592-023-02007-6","volume":"20","author":"FA Rosenberger","year":"2023","unstructured":"Rosenberger FA, Thielert M, Strauss MT, Schweizer L, Ammar C, Madler SC, Metousis A, et al. Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome. Nat Methods. 2023;20:1530\u20136.","journal-title":"Nat Methods"},{"key":"1590_CR36","doi-asserted-by":"publisher","first-page":"732929","DOI":"10.3389\/fphys.2021.732929","volume":"12","author":"RP Cunningham","year":"2021","unstructured":"Cunningham RP, Porat-Shliom N. Liver Zonation - Revisiting Old Questions With New Technologies. Front Physiol. 2021;12:732929.","journal-title":"Front Physiol"},{"key":"1590_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2023.12.023","volume":"80","author":"TS Andrews","year":"2024","unstructured":"Andrews TS, Nakib D, Perciani CT, Ma XZ, Liu L, Winter E, Camat D, et al. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. J Hepatol. 2024;80:730\u201343.","journal-title":"J Hepatol"},{"key":"1590_CR38","doi-asserted-by":"publisher","first-page":"716415","DOI":"10.3389\/fmolb.2021.716415","volume":"8","author":"L Yang","year":"2021","unstructured":"Yang L, Lu P, Yang X, Li K, Qu S. Annexin A3, a Calcium-Dependent Phospholipid-Binding Protein: Implication in Cancer. Front Mol Biosci. 2021;8:716415.","journal-title":"Front Mol Biosci"},{"key":"1590_CR39","first-page":"6657","volume":"18","author":"C Zhuang","year":"2019","unstructured":"Zhuang C, Wang P, Sun T, Zheng L, Ming L. Expression levels and prognostic values of annexins in liver cancer. Oncol Lett. 2019;18:6657\u201369.","journal-title":"Oncol Lett"},{"key":"1590_CR40","doi-asserted-by":"publisher","first-page":"e100515","DOI":"10.1371\/journal.pone.0100515","volume":"9","author":"SC Wei","year":"2014","unstructured":"Wei SC, Tan YY, Weng MT, Lai LC, Hsiao JH, Chuang EY, Shun CT, et al. SLCO3A1, A novel crohn\u2019s disease-associated gene, regulates nf-kappaB activity and associates with intestinal perforation. PLoS ONE. 2014;9:e100515.","journal-title":"PLoS ONE"},{"key":"1590_CR41","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1053\/j.gastro.2018.07.031","volume":"155","author":"Q Pan","year":"2018","unstructured":"Pan Q, Zhang X, Zhang L, Cheng Y, Zhao N, Li F, Zhou X, et al. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology. 2018;155:1578\u201392. e1516.","journal-title":"Gastroenterology"},{"key":"1590_CR42","doi-asserted-by":"publisher","first-page":"19736","DOI":"10.1038\/s41598-020-76875-9","volume":"10","author":"W Udomsinprasert","year":"2020","unstructured":"Udomsinprasert W, Poovorawan Y, Chongsrisawat V, Vejchapipat P, Honsawek S. Decreased circulating clusterin reflects severe liver complications after hepatoportoenterostomy of biliary atresia. Sci Rep. 2020;10:19736.","journal-title":"Sci Rep"},{"key":"1590_CR43","doi-asserted-by":"crossref","unstructured":"Li H, Lan L, Chen H, Zaw Thin M, Ps H, Nelson JK, Evans IM et al. SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Nature 2025.","DOI":"10.1038\/s41586-025-09574-y"},{"key":"1590_CR44","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/hep.31582","volume":"73","author":"Z Song","year":"2021","unstructured":"Song Z, Chen W, Athavale D, Ge X, Desert R, Das S, Han H, et al. Osteopontin Takes Center Stage in Chronic Liver Disease. Hepatology. 2021;73:1594\u2013608.","journal-title":"Hepatology"},{"key":"1590_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.acthis.2010.03.004","volume":"113","author":"KS Koch","year":"2011","unstructured":"Koch KS, Leffert HL. Ectopic expression of CD74 in Ikkbeta-deleted mouse hepatocytes. Acta Histochem. 2011;113:428\u201335.","journal-title":"Acta Histochem"},{"key":"1590_CR46","doi-asserted-by":"publisher","first-page":"1437113","DOI":"10.3389\/fphar.2024.1437113","volume":"15","author":"B Liu","year":"2024","unstructured":"Liu B, Li F, Wang Y, Gao X, Li Y, Wang Y, Zhou H. APP-CD74 axis mediates endothelial cell-macrophage communication to promote kidney injury and fibrosis. Front Pharmacol. 2024;15:1437113.","journal-title":"Front Pharmacol"},{"key":"1590_CR47","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1007\/s11033-023-08623-x","volume":"50","author":"X Xing","year":"2023","unstructured":"Xing X, Cao F, Gao L, Song M. AHSG, a Gene Promoting Tumour Proliferation, Migration and Invasion, is an Independent Prognostic Factor for Poor Overall Survival in Lung Adenocarcinoma. Mol Biol Rep. 2023;50:7659\u201366.","journal-title":"Mol Biol Rep"},{"key":"1590_CR48","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.18632\/aging.202586","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yang B, Chen D, Zhou X, Wang M, Jiang J, Wei L, et al. Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma. Aging. 2021;13:4696\u2013712.","journal-title":"Aging"},{"key":"1590_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.18632\/oncotarget.28426","volume":"14","author":"A Escudero-Esparza","year":"2023","unstructured":"Escudero-Esparza A, Bartoschek M, Gialeli C, Okroj M, Owen S, Jirstrom K, Orimo A, et al. Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer. Oncotarget. 2023;14:481\u20132.","journal-title":"Oncotarget"},{"key":"1590_CR50","doi-asserted-by":"publisher","first-page":"76920","DOI":"10.18632\/oncotarget.12729","volume":"7","author":"A Escudero-Esparza","year":"2016","unstructured":"Escudero-Esparza A, Bartoschek M, Gialeli C, Okroj M, Owen S, Jirstrom K, Orimo A, et al. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer. Oncotarget. 2016;7:76920\u201333.","journal-title":"Oncotarget"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01590-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01590-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01590-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:34:29Z","timestamp":1785454469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01590-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01590-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8339668\/v1","asserted-by":"object"}]},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Huiping Zhou is the corresponding author and is also an Editor for the journal.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed following institutional guidelines for ethical animal studies and approved by the Virginia Commonwealth University and Richmond VA Medical Center Institutional Animal Care and Use Committee, Virginia, USA. All patient samples used followed Richmond VA Medical Center Institutional Review Board guidelines for de-identified consenting patients.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"84"}}